tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX

Protagonist Therapeutics (PTGX) Similar Stocks

Compare
656 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Protagonist Therapeutics
$44.49
$2.73B
10.58
74.06%
9 Buy
1 Hold
0 Sell
Strong Buy
ACADIA Pharmaceuticals
$14.73
$2.46B
10.83
-13.86%
11 Buy
6 Hold
0 Sell
Moderate Buy
Viking Therapeutics
$24.99
$2.81B
-66.87%
15 Buy
2 Hold
0 Sell
Strong Buy
Merus
$43.57
$3.01B
-3.41%
15 Buy
0 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$38.27
$3.30B
-30.20%
12 Buy
6 Hold
1 Sell
Moderate Buy
Scholar Rock Holding
$32.81
$3.11B
120.35%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PTGX
Protagonist Therapeutics
44.49
18.93
74.06%
ACAD
ACADIA Pharmaceuticals
14.73
-2.37
-13.86%
VKTX
Viking Therapeutics
24.99
-50.43
-66.87%
MRUS
Merus
43.57
-1.54
-3.41%
CRSP
Crispr Therapeutics AG
38.27
-16.56
-30.20%
SRRK
Scholar Rock Holding
32.81
17.92
120.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis